arrow_back Back to App

Preventing Drug Shortages and Improving Drug Quality

New regulations aim to ensure a steady supply of essential medicines, especially injectable drugs. Citizens can expect better availability and quality of medications, thanks to extended expiration dates and support for modern manufacturing methods. Pharmaceutical companies will need to collaborate more closely with authorities to prevent supply disruptions.
Key points
Extended Drug Expiration Dates: Essential drugs may have their expiration dates extended, reducing the risk of shortages in pharmacies.
Improved Drug Quality: A pilot program will assess how well companies manage drug manufacturing quality, especially for injectable drugs.
Timely Shortage Notifications: Companies must report potential drug shortages faster, with financial penalties for delays.
Support for Modern Manufacturing: The government will provide funds to support companies adopting more efficient, continuous drug production methods to prevent shortages.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_2595
Sponsor: Sen. Cardin, Benjamin L. [D-MD]
Process start date: 2021-08-04
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Drug Shortages Prevention and Quality Improvement Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_2595.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-08-04.

What are the main provisions?

Key points include:

  • Extended Drug Expiration Dates: Essential drugs may have their expiration dates extended, reducing the risk of shortages in pharmacies.
  • Improved Drug Quality: A pilot program will assess how well companies manage drug manufacturing quality, especially for injectable drugs.
  • Timely Shortage Notifications: Companies must report potential drug shortages faster, with financial penalties for delays.
  • Support for Modern Manufacturing: The government will provide funds to support companies adopting more efficient, continuous drug production methods to prevent shortages.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Cardin, Benjamin L. [D-MD].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health